Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2023 07:28 ET | Source: KuicK Research

Ociperlimab Clinical Trials Development Insight

Delhi, April 27, 2023 (GLOBE NEWSWIRE) -- PD-1 and CTLA-4 were the first immune checkpoints that were used as therapeutic targets by drug makers. Years later, a new generation of immune checkpoint...